Review Article: Egyptian Efforts to Control Hepatitis C Virus in Egypt | ||||
| Alfarama Journal of Basic & Applied Sciences | ||||
| Article 10, Volume 6, Issue 2, April 2025, Page 253-262 PDF (989.04 K) | ||||
| Document Type: Review Article | ||||
| DOI: 10.21608/ajbas.2025.362040.1251 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Mohammed El Behery1; Ahmed I. Elghwab  1; Ashraf Tabll2; El-Sherbiny hamdi El-Sayed1; Mohamed A. Abdelrazek 3
| ||||
| 1Chemistry Department, Faculty of Science, Port Said University, Port Said 42521, Egypt | ||||
| 2Genetic Engineering and Biotechnology Research Division, National Research Center, Egypt | ||||
| 3Biotechnology Research Center, 23 July St., Industrial Zone, New Damietta, Egypt | ||||
| Abstract | ||||
| ABSTRACT Worldwide, hepatitis C virus (HCV) represents a great risk to public health and is associated with life-threatening outcomes. Since Egypt historically has the highest HCV incidence rates in the world, this virus is providing serious social and economic issues to millions of Egyptians. For HCV combating, the Egyptian nationwide HCV elimination program considered as achievement prime example, having cured over 90% of HCV Egyptian infected patients. Thus, it is markedly reducing the disease’s prevalence and incidence. Other African countries with similar HCV prevalence and incidence rates might greatly benefit from Egypt’s program, which give flexible frameworks and important insights. The aim of this review is to shed the light on the Egyptian program challenges and successes in combating the great HCV public health problem. The aim of this review is to shed the light on the Egyptian program challenges and successes in combating the great HCV public health problem. | ||||
| Keywords | ||||
| HCV; Egypt; Direct acting anti-viral agents; NCCVH | ||||
|
Statistics Article View: 131 PDF Download: 221 |
||||
